Videos
Press Releases
2 Feb 2021
PRESS RELEASE: EORTC 1945 OligoRARE trial in oligometastatic rare cancers receives support by Anticancer Fund & Rising Tide Foundation
20 Jan 2021
PRESS RELEASE: First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study
19 Sep 2020
PRESS RELEASE: KEYTRUDA® (pembrolizumab) Reduced the Risk of Distant Metastasis or Death by 40% Compared Versus Placebo as Adjuvant Treatment in Resected, High-Risk Stage III Melanoma
16 Jul 2020
PRESS RELEASE: Advocacy Organizations and Professional Societies from Across the Globe Unite on Brain Tumour Patients’ Charter of Rights
Latest Newsletters
News
17 Oct 2023
EORTC’s presence at ESMO 2023
4 Oct 2023
The EU funded project LEGATO officially started
26 Sep 2023
EORTC strategic meeting with Middle Eastern Ambassadors
22 Sep 2023
EORTC Quality of Life Group projects to be presented at ISOQOL 2023
17 Jul 2023
Celebrating Sarcoma Awareness Month with the start of EU-funded STREXIT 2 project study
30 Jun 2023
“Best Proposal in Medicine” award received by EORTC at the PTCOG 61 Conference
16 Jun 2023
Long-term efficacy and safety outcomes of the EORTC/LYSA/FIL H10 trial assessing early PET-scan adapted treatment of limited stage Hodgkin lymphoma
9 Jun 2023
Joint Statement: health organisations define EHDS’ opt out required for life saving research
7 Jun 2023
Congratulations to Dr. Hans Wildiers, winner of the B.J. Kennedy Geriatric Oncology Award
6 Jun 2023
Full validation of the EORTC CAT Core
